Keshab Sarma

914 total citations
24 papers, 439 citations indexed

About

Keshab Sarma is a scholar working on Organic Chemistry, Physical and Theoretical Chemistry and Molecular Biology. According to data from OpenAlex, Keshab Sarma has authored 24 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 7 papers in Physical and Theoretical Chemistry and 6 papers in Molecular Biology. Recurrent topics in Keshab Sarma's work include Asymmetric Synthesis and Catalysis (5 papers), Chemical Synthesis and Analysis (3 papers) and Hepatitis C virus research (3 papers). Keshab Sarma is often cited by papers focused on Asymmetric Synthesis and Catalysis (5 papers), Chemical Synthesis and Analysis (3 papers) and Hepatitis C virus research (3 papers). Keshab Sarma collaborates with scholars based in United States, Germany and Switzerland. Keshab Sarma's co-authors include W. von E. Doering, David B. Smith, Ludmila Bîrlădeanu, Gerhard Schröder, Wen-Rong Jiang, Vincent Lévêque, Klaus Klumpp, Isabel Nájera, Dieter Heindl and Hyunsoon Kang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Keshab Sarma

24 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keshab Sarma United States 12 182 133 124 123 98 24 439
M. K. HOLLOWAY United States 10 145 0.8× 132 1.0× 122 1.0× 76 0.6× 55 0.6× 12 381
Esmir Gunić United States 17 286 1.6× 254 1.9× 133 1.1× 64 0.5× 71 0.7× 25 793
Yat Sun Or United States 19 446 2.5× 387 2.9× 192 1.5× 189 1.5× 316 3.2× 47 1.1k
James Gillard Canada 19 469 2.6× 314 2.4× 273 2.2× 330 2.7× 177 1.8× 30 975
Steven Swallow United Kingdom 13 419 2.3× 162 1.2× 93 0.8× 45 0.4× 44 0.4× 19 616
Norman Aubry Canada 14 129 0.7× 255 1.9× 133 1.1× 162 1.3× 86 0.9× 23 545
Jimmy Lindberg Sweden 14 220 1.2× 370 2.8× 315 2.5× 233 1.9× 202 2.1× 24 844
Thomas Gossas Sweden 14 183 1.0× 332 2.5× 71 0.6× 70 0.6× 25 0.3× 21 583
Stéphane Bogen United States 17 460 2.5× 173 1.3× 233 1.9× 306 2.5× 183 1.9× 59 932
Charles A. Flentge United States 9 233 1.3× 212 1.6× 445 3.6× 80 0.7× 101 1.0× 14 738

Countries citing papers authored by Keshab Sarma

Since Specialization
Citations

This map shows the geographic impact of Keshab Sarma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keshab Sarma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keshab Sarma more than expected).

Fields of papers citing papers by Keshab Sarma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keshab Sarma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keshab Sarma. The network helps show where Keshab Sarma may publish in the future.

Co-authorship network of co-authors of Keshab Sarma

This figure shows the co-authorship network connecting the top 25 collaborators of Keshab Sarma. A scholar is included among the top collaborators of Keshab Sarma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keshab Sarma. Keshab Sarma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bringley, Dustin A., Benjamin Roberts, Selçuk Çalimsiz, et al.. (2021). Synthesis of Rovafovir Etalafenamide (Part II): Dynamic Control for Successful Scale-Up of an Oxygen-Releasing Elimination Reaction Mediated by Oxone. Organic Process Research & Development. 25(5). 1237–1246. 1 indexed citations
2.
Çalimsiz, Selçuk, Keshab Sarma, Jinyu Shen, et al.. (2021). Synthesis of Rovafovir Etalafenamide (Part IV): Evolution of the Synthetic Process to the Fluorinated Nucleoside Fragment. Organic Process Research & Development. 25(5). 1263–1274. 2 indexed citations
3.
Lou, Yan, Zachary K. Sweeney, A. Kuglstatter, et al.. (2014). Finding the perfect spot for fluorine: Improving potency up to 40-fold during a rational fluorine scan of a Bruton’s Tyrosine Kinase (BTK) inhibitor scaffold. Bioorganic & Medicinal Chemistry Letters. 25(2). 367–371. 29 indexed citations
4.
Hong, Jun‐Bae, et al.. (2013). Development of a Scalable Synthesis of a Bruton’s Tyrosine Kinase Inhibitor via C–N and C–C Bond Couplings as an End Game Strategy. Organic Process Research & Development. 18(1). 228–238. 14 indexed citations
5.
Liu, Yanzhou, et al.. (2010). Isolation and identification of ester impurities in RG7128, an HCV polymerase inhibitor. Journal of Pharmaceutical and Biomedical Analysis. 53(3). 710–716. 6 indexed citations
6.
Davidson, James P., et al.. (2010). A Synthesis of 3,5-Disubstituted Phenols. Organic Process Research & Development. 14(2). 477–480. 15 indexed citations
7.
Brandl, Michael, Xiaoyang Wu, Hong Lei, et al.. (2008). Physicochemical Properties of the Nucleoside Prodrug R1626 Leading to High Oral Bioavailability. Drug Development and Industrial Pharmacy. 34(7). 683–691. 29 indexed citations
8.
Klumpp, Klaus, David B. Smith, Michael Brandl, et al.. (2007). Design and Characterization of R1626, A Prodrug of the HCV Replication Inhibitor R1479 (4′-Azidocytidine) With Enhanced Oral Bioavailability. Antiviral Research. 74(3). A35–A35. 6 indexed citations
9.
Klumpp, Klaus, Vincent Lévêque, Sophie Le Pogam, et al.. (2005). The Novel Nucleoside Analog R1479 (4′-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture. Journal of Biological Chemistry. 281(7). 3793–3799. 166 indexed citations
10.
Connolly, Terrence J., et al.. (2004). Process Development and Scale-up of a Selective α1-Adrenoceptor Antagonist. Organic Process Research & Development. 9(1). 80–87. 16 indexed citations
11.
Chen, Jian Jeffrey, Nolan Dewdney, Xiaohong Lin, et al.. (2003). Design and synthesis of orally active inhibitors of TNF synthesis as anti-rheumatoid arthritis drugs. Bioorganic & Medicinal Chemistry Letters. 13(22). 3951–3954. 8 indexed citations
12.
Ranganathan, Darshan, Anup Thomas, V. Haridas, et al.. (1999). Design, Synthesis, and Characterization of Tyrosinophanes, a Novel Family of Aromatic-Bridged Tyrosine-Based Cyclodepsipeptides. The Journal of Organic Chemistry. 64(10). 3620–3629. 16 indexed citations
13.
Doering, W. von E., Ludmila Bîrlădeanu, Keshab Sarma, & Liming Shao. (1996). The Cyclohexadienyl Radical in the Thermal Syn−Anti Isomerization of Two Crossed Pentaenes of the Type of Bis-Homofulvalene [J. Am. Chem. Soc. 1996, 118, 6660−6665].. Journal of the American Chemical Society. 118(37). 8985–8985. 1 indexed citations
14.
Doering, W. von E., et al.. (1996). The Cyclohexadienyl Radical in the Thermal Syn−Anti Isomerization of Two Crossed Pentaenes of the Type of Bis-Homofulvalene. Journal of the American Chemical Society. 118(28). 6660–6665. 2 indexed citations
15.
16.
17.
Doering, W. von E., et al.. (1991). Two factors in thermal cis-trans rearrangement of pentaenes: configuration in (E,E)-octahydro-2,2'(3H,3'H)-binaphthylidene and extensivity in 2,2'- and 3,3'-bicholestadienylidenes. Journal of the American Chemical Society. 113(12). 4558–4563. 13 indexed citations
18.
Sarma, Keshab, et al.. (1986). Beeinflussung der Gleichgewichtslage bei monosubstituierten Bullvalenen und Cycloheptatrienen durch XCH2− und X2CH‐Reste. Chemische Berichte. 119(9). 2889–2894. 1 indexed citations
19.
Sarma, Keshab, et al.. (1986). ChemInform Abstract: Concerning the Question of Positional Isomerism in Disubstituted Bullvalenes.. Chemischer Informationsdienst. 17(45). 1 indexed citations
20.
Sarma, Keshab, et al.. (1983). Bullvaleno‐kronenether – Kronenether mit variablen Ringgrößen. Chemische Berichte. 116(12). 3800–3812. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. K. HOLLOWAY Breakdown of academic impact, for papers by Esmir Gunić Breakdown of academic impact, for papers by Yat Sun Or Breakdown of academic impact, for papers by James Gillard Breakdown of academic impact, for papers by Steven Swallow Breakdown of academic impact, for papers by Norman Aubry Breakdown of academic impact, for papers by Jimmy Lindberg Breakdown of academic impact, for papers by Thomas Gossas Breakdown of academic impact, for papers by Stéphane Bogen Breakdown of academic impact, for papers by Charles A. Flentge
Rankless by CCL
2026